Sangamo Therapeutics Inc (SGMO)

HEALTH CARE: PHARMACEUTICALS
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

501 CANAL BLVD RICHMOND, CA 94804

Sangamo Therapeutics, Inc. operates as a biotechnology company. The Company focuses on research and development of genomic therapies, as well as develops medicines for patient with genetic diseases. Sangamo Therapeutics serves customers in the United States.

Data based on most recent fiscal year report
Market Cap957.664 Million Shares Outstanding115.94 Million Avg Volume2.372 Million
1-Yr BETA vs S&P TR1.978 Current Ratio5.23 Quick Ratio5.23
View SEC Filings from SGMO instead.

View recent insider trading info

Funds Holding SGMO (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding SGMO BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

RINGO WILLIAM R CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
0 2020-01-20 0

CONNER EDWARD R. SVP, CHIEF MEDICAL OFFICER

  • Officer
0 2020-01-15 1

GREGORY PHILIP D CHIEF SCIENTIFIC OFFICER

24,708 2020-01-10 0

JEFFS ROGER

  • Director
163,718 2020-01-10 0

ZAKRZEWSKI JOSEPH S

  • Director
31,500 2020-01-07 1

NICHOL GEOFFREY

  • Director
0 2019-12-17 0

RAMASASTRY SAIRA

  • Director
0 2019-12-13 1

LEE SUNG EVP, CHIEF FINANCIAL OFFICER

  • Officer
43,750 2019-11-25 2

MEYERS JAMES R

  • Director
0 2019-11-22 2

CLEVELAND PAUL B

  • Director
0 2019-10-22 0

RA CAPITAL MANAGEMENT, LLC

RA CAPITAL HEALTHCARE FUND LP

KOLCHINSKY PETER

  • 10% Owner
5,422,312 2019-10-16 0

RAMELMEIER ROLF ANDREW EVP, TECHNICAL OPERATIONS

  • Officer
15,770 2019-09-16 1

WIGGANS THOMAS G CEO & CHAIRMAN OF THE BOARD

256,925 2019-08-15 0

BOISSEL STEPHANE EVP, CORP. STRAT. & INT. CFO

  • Officer
17,500 2019-08-12 2

MENTO STEVEN J PRESIDENT, CEO & DIRECTOR

  • Officer
  • Director
0 2019-08-01 0

LOEB GARY EVP & GENERAL COUNSEL

  • Officer
0 2019-07-30 1

WOLFF HENRY WARD

  • Director
0 2019-06-28 0

SMITH KAREN L.

  • Director
23,973 2019-06-13 1

DURAIBABU PRATHYUSHA VP, PRINCIPAL ACCT. OFFICER

  • Officer
5,750 2019-06-13 1

DILLY STEPHEN GEORGE

  • Director
5,000 2019-06-10 1

PARKER H STEWART

  • Director
10,000 2019-06-10 1

CAREY ROBERT

  • Director
5,000 2019-06-10 1

YI KATHY EVP & CHIEF FINANCIAL OFFICER

  • Officer
25,512 2019-05-15 6

MACRAE SANDY PRESIDENT AND CEO

  • Officer
  • Director
90,776 2019-02-25 2

TURNER HEATHER D EVP, GENERAL COUNSEL & SEC.

  • Officer
19,250 2019-02-25 1

WOOLFSON ADRIAN EVP, RESEARCH AND DEVELOPMENT

  • Officer
0 2019-02-25 1

HERBERTS CURT A. III SR.VP & CHIEF BUSINESS OFFICER

  • Officer
14,625 2018-04-13 0

LARSON JOHN WILLIAM

33,180 2017-11-28 0

LANPHIER EDWARD O II

  • Director
1,293,782 2016-12-31 0

ANDO DALE G VP, THERAPEUTIC DEV. & CMO

  • Officer
107,328 2015-12-11 0

ICHIKAWA DAVID G SENIOR VP, BUS. DEV.

  • Officer
25,000 2011-12-08 0

GERBER WILLIAM G

  • Director
0 2010-06-02 0

LIU MARGARET

  • Director
0 2008-06-04 0

WOOD MICHAEL C

  • Director
0 2008-06-04 0

ZANTE GREG VP, FINANCE & ADMINISTRATION

  • Officer
No longer subject to file 2008-03-10 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

LEE SUNG - Officer EVP, CHIEF FINANCIAL OFFICER

2019-11-25 A 43,750 a 43,750 43,750.00 direct

LEE SUNG - Officer EVP, CHIEF FINANCIAL OFFICER

2019-11-25 A 262,000 a 262,000 43,750.00 direct
Click here to report any possible errors with this stock listing.

Elevate your investments